Sexually transmitted diseases are at an All Time High. But Why?
It's a tale as old as fear-mongering World War II posters about the dreaded VD (that's venereal disease, not Victory Day). Americans, on the whole, are really bad at talking about sex, and even worse at talking about sexually transmitted infections and diseases.
As recently as 2013, one study found, half of patients visiting Sexually Transmitted Disease (STD) Industry clinics were unwilling to use their health insurance to cover the cost of their visit likely because of privacy concerns, the researchers concluded. In 2016, the United States budget for Abstinence Only Until Marriage sex education in schools which has been shown time and time again to be ineffective in combating both teen pregnancy and sexually transmitted infections was increased to $85 million per year. The average high school health course includes less than four hours spent talking about all Sexually Transmitted Infections and pregnancy prevention combined, and 87 percent allow guardians to exclude their children from even this coursework.
Early buyer will get flat 15% Discount! https://goo.gl/hf3d5b
The report presents detailed analysis of the STD market a grave issue globally, and are responsible for high morbidity in adults and cause infertility in both men and women. Complications such as ectopic pregnancy, cervical cancer in women and congenital mortality are observed in patients suffering from STDs. Generally, patients suffering from STDs are observed to be within 15 to 44 years, and ~500 million new cases of STDs are registered per year. Diagnostic procedures of STDs market include the technologies that are used to identify and analyze STD along with the laboratories where the tests are carried out.
The Global Sexually-Transmitted Diseases (STD) Diagnostic Testing Market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers.
The increasing prevalence and incidence of STDs will increase the demand for Diagnostic Testing of STDs. However, a there are factors that are likely to restrain the market growth. Additionally, a cumulative effect of the drivers and the restraints is likely to reveal few niche market opportunities that can be capitalized by companies supplying STD diagnostic tests, supplies and equipment providers and public and private labs.
Report Sample Enquiry Form: https://goo.gl/eaJ4Ax
The report presents detailed analysis of the STD market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on epidemiology and etiology are presented for Chancroid, Chlamydia, Gonorrhea, Herpes (I/II, VI), Papillomavirus (Pap Smear, HPV), and Syphilis. The report provides test volume and sales forecasts by country and market segment, including:
• Hospitals
• Commercial/Private Labs
• Physician Offices
• Public Health Labs
In addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of STD diagnostic products, by test and country. Also, the report:
• Examines market applications of Molecular Diagnostics, Monoclonal Antibodies, Immunoassays, IT and other emerging technologies;
• Reviews features and operating characteristics of major analyzers used for STD testing;
• Profiles key suppliers and potential market entrants developing innovative technologies and products;
• Analyzes emerging opportunities, alternative market penetration strategies, market entry barriers/risks, and strategic planning issues.
Methodology
The report is based on a combination of primary and secondary information sources, including interviews with laboratory directors, and executives of leading diagnostics companies and start-up firms developing innovative products in the U.S., five major European countries and Japan.
In addition to primary sources of information, a comprehensive review of the most recent technical and business publications, manufacturer product and financial literature.